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Abstract 
Chronic Heart Failure (CHF) adversely affects 300,000 Australians. Symptom 
stabilisation and prognosis are partially determined by the patient’s adherence to 
medical and lifestyle recommendations. To test the hypothesis that depression, 
anxiety, and self-efficacy are independent predictors of adherence behaviour, 115 
predominately male (70.6%) volunteers with a mean age of 63.57 were recruited from 
a major teaching hospital in Australia.  Depression (33.3% scored > 10 on BDI) failed 
to predict adherence.  Trait anxiety (31% scored > 40 on STAI) explained minimal 
variability regarding smoking and alcohol adherence.  Self-efficacy strongly predicted 
adherence to most recommendations. Findings have implications for cardiac nurses 
regarding strategies to optimize adherence and quality of life, and minimise public 
health costs.  
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Psychological Factors and Treatment Adherence Behaviour in Patients with 
Chronic Heart Failure 
Chronic Heart Failure (CHF) is a progressively debilitating condition affecting 
approximately 300 000 Australians and accounting for over 40,000 hospital 
admissions in the year 2000 to 2001 (e.g., Krum, 2001). Patients may experience 
reduced quality of life (Blyth et al., 1997), restricted physical and social functioning 
(Moser & Worster, 2000), and frequent hospitalisation resulting in significant public 
health costs (Krum, 2001).  Functional state and disease progression is partially 
determined by the CHF patient’s adherence to self-maintenance protocols (Bellg, 
2004).  Despite prolific research regarding the association between psychological 
factors and cardiovascular disease, few studies have examined the association 
between psychological factors and treatment adherence.  
Chronic Heart Failure and Adherence to Self-maintenance Recommendations 
Chronic heart failure occurs when the ability of the myocardium to effectively 
circulate blood throughout the body has been compromised, culminating in difficulty 
maintaining fluid and sodium homeostasis (Bellg, 2004). Symptoms may include: 
dyspnea, restricted exercise tolerance, orthopnea, lethargy, fatigue, oedema, 
pulmonary congestion, and fluid retention (Bellg, 2004) with detrimental 
consequences regarding activities of daily living, socialisation, general quality of life, 
and psychological distress.  
Treatment is directed towards retarding disease progression, providing 
symptom relief and prolonging survival, with nursing staff playing a vital role in 
terms of individual cardiac nursing and health promotion. The Australian National 
Heart Foundation (ANHF) and Medical Research Council has established guidelines 
for non-pharmacological management which includes: ongoing medical support, 
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severely restricted or complete abstinence of alcohol and nicotine, restricting sodium 
intake, restricting daily fluid intake, regular exercise, daily weighing, and regular 
influenza and pneumonia vaccinations (Krum, 2001).  
Research suggests that adherence levels fluctuate between recommendations 
and is influenced by factors other than knowledge. Reported adherence has been 
relatively high with regards to keeping medical appointments (95.7%), restricting 
nicotine (95.4%) alcohol restrictions (91.61%), and administering medications 
(91.4%) (Evangelista et al., 2003). Dietary and exercise adherence were considerably 
lower at 70.9% and 61.1% respectively with individuals under 65 years reporting 
lowest levels. Ni et al. (1999) reported lower levels of adherence regarding daily 
weighing (58%) and sodium restriction (38%) with less 30% of patients reporting that 
they never exercised (Ni et al., 1999). Interestingly a recent study based upon a small 
homogenous sample (i.e., all male, n = 39), reported high levels of adherence with 
78% of participants adhering to a home-based exercise program (Corvera-Tindel, 
Doering, Gomez & Dracup, 2004).  
Prevalence of Depression and the Relationship with Poor Outcomes and Adherence 
 
Havranek, Ware and Lowes (1999) found that 24.4% of CHF individuals 
experienced depression.  A longitudinal study (Fulop, Strain & Stettin, 2003) found 
that on discharge, 36% of CHF patients reported depressive symptomatology with 
22% meeting major depression criteria (DSM-III-R). Depression remained evident in 
53% and 29% of participants, at 1 month and 6 months respectively.  While divergent 
findings are evident, several CHF studies demonstrated a positive association between 
depression and poor outcomes (Moser & Worster, 2000).  For instance, patients 
diagnosed with major depression were found to have a mortality rate twice that of 
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non-depressed patients and were three times more likely to be readmitted to hospital 
(Jiang, Krishnan & O’Connor, 2002).  
The precise mechanism underlying the relationship between depression, 
cardiovascular disease and poor health outcomes remains inconclusive with 
pathological and behavioural factors nominated as potential influencing variables 
(Joynt, Whellan & O’Connor, 2003). The physiological sequela associated with 
depression, such as platelet aggregation, systemic and localised inflammatory 
responses, restricted heart rate variability or arrhythmias, and endocrine activation, 
may precipitate the development of cardiac conditions and compromise weakened 
cardiovascular functioning (Jiang et al., 2002). This association between depression 
and poor outcomes may be partly mediated by adherence behaviour (Joynt et al., 
2003). 
Depressed individuals are more likely to engage in behaviours, such as 
smoking, overeating and adopting a sedentary lifestyle (Gala, Galletti & Invernizzi, 
1997). Depressive symptoms such as low energy levels, lack of motivation, and a 
sense of helplessness or despondency (Gala et al.), and cognitive dysfunction (e.g., 
attention and memory deficits) (Wang et al., 2002) may interfere with ability to 
perform self-maintenance recommendations. Depression is frequently associated with 
non-adherence in patients suffering from chronic illnesses (Katon, 2003), however, a 
recent study failed to show a relationship between depression and exercise adherence 
in individuals with CHF (Corvera-Tindel et al., 2004).   
Anxiety and Chronic Heart Failure 
According to Spielberger, trait anxiety refers to the personality disposition 
whereby an individual perceives stressful situations as being extremely threatening 
and will subsequently respond with intense fear, worry and/or nervousness (1983). A 
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recent study reported moderate levels of anxiety amongst CHF participants (Dracup et 
al., 2003). Anxiety and associated physiological reactions such as increased 
sympathetic nervous system activation, tachycardia, and increased respiratory rate 
(Edelmann, 1992), have been associated with cardiovascular disease development and 
a predictor of increased health care consumption and morbidity following myocardial 
infarction (Strik, Denollet, Lousberg & Honig, 2003). Anxiety sensitivity has shown 
strong positive associations with alcohol consumption (Stewart, Samoluk & 
MacDonald, 1999) suggesting that there may be an association between anxiety and 
high-risk behaviours.  
The Concept of Self-efficacy and its Relationship to Adherence 
Self-efficacy refers to the judgement individuals develop regarding their 
ability to successfully perform specific behaviours (Bandura, 1997).  Bandura 
postulated that self-efficacy influences behavioural engagement, degree of expended 
effort, perseverance, resiliency and the level of achievement. Self-efficacy is used 
increasingly in health research as a predictor of behaviour. An association has been 
found between poor adherence and low levels of self-efficacy in the CHF population, 
however, self-efficacy was globally operationalised as confidence in maintaining 
health and controlling CHF symptomatology (Ni et al., 1999).  
Hypotheses 
This study will examine the prevalence of anxiety and depression in CHF 
patients and explore the level of adherence to self-maintenance recommendations.  It 
is hypothesised that depression, anxiety, and self-efficacy will be significant 
independent predictors of adherence to seven self-maintenance behaviours after 
controlling for demographic and biological factors.  With consideration towards 
previous findings, the potential influence of participant age and gender and their level 
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or functioning (physical and physiological) upon adherence behaviour were controlled 
for in order to identify the ability of target independent variables to explain adherence 
variability. 
Method 
  
Participants 
 
Patients receiving treatment through an Australian hospital for diagnosed CHF 
were eligible for inclusion. Persons awaiting heart transplant surgery and patients with 
diagnosed dementia or severe communication deficits were excluded.  In total, 115 
patients were recruited from two sources: hospital admissions (81) and attendance at a 
specialist Outpatient Unit (34).   
Materials 
 
The protocol included a demographic section, Beck Depression Inventory 
(BDI), State-Trait Anxiety Inventory - T (STAI-T), Self-Care of Heart Failure Index 
(SCHFI), the Heart Failure Compliance Questionnaire (HFCQ) and a measure of 
adherence.  
The BDI assesses the intensity of 21 depressive symptoms and attitudes (Beck 
& Steer, 1993).  Responses are made on a 4-point scale with larger scores with higher 
levels of depressive symptomatology. Scores of less than 10 indicate minimal 
depression, 10 to 16 indicate mild depression, 17 to 29 indicate moderate depression 
and scores greater than 29 indicate severe depression. A meta-analysis of internal 
consistency in non-psychiatric patients reported a Cronbach α of .81 and test-retest 
reliability of .83 (Lane, Carroll, Ring, Beevers & Lip, 2002).     
The STAI-T (form Y), the second of two subscales, contains 20 items which 
assess trait anxiety (Spielberger, 1983).  These statements are measured on a 4-point 
scale with potential scores ranging between 20 and 80.  This scale has been used 
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extensively to assess clinical anxiety in patient and general populations.  Spielberger 
(1983) reports that the STAI-T correlates highly with other trait anxiety scales and has 
high test-retest reliability and internal consistency (median coefficient = .90).  
The SCHFI is a self-report measure comprising of three subscales with the 
first, self-care maintenance, being used within this study.  This section consists of 6 
items, rated on a four-point scale.  Reported reliability for subscales ranges between 
.56 and .82 and construct validity ranges between .69 to .73 (Riegel et al., 2004). This 
scale was used to compare adherence with the recommended behaviours measured by 
the study-specific measure (see below).  
The HFCQ assesses adherence to six recommended behaviours; keeping 
medical appointments, following dietary recommendations, exercising, administering 
medications, and the cessation of smoking and alcohol.  The frequency and level of 
difficulty of individual behaviours, is measured on a 4-point scale with reasons for 
difficulty measured by fixed choice format. Patients reported level of adherence has 
been found to be significantly correlated with their adherence behaviour as rated by 
their family members and reported as ranging between .35 and .78 on assessed health 
behaviours (Evangelista et al., 2003).  Internal consistency reliability (i.e., total 
adherence score) has been reported at .68.  This measure was used for descriptive 
purposes and to identify reasons for non-adherence. 
As the SCHFI did not assess adherence to all of the recommended behaviours 
included within this study, a study specific questionnaire, based upon ANHF 
recommendations, was developed measuring target behaviours: daily weighing, 
sodium restriction, 1500ml daily fluid restrictions, administering medications as 
prescribed, gentle and vigorous exercise, and avoidance of smoking and alcohol.  
Adherence to each of the aforementioned recommendations except smoking and 
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exercise was assessed on a 7-point scale ranging from never to every day.  Smoking 
was measured on a 4-point scale from not at all to daily while exercise was assessed 
via a 6-point scale from never to more than once per day.  Self-efficacy regarding 
individual behaviours was assessed according to two areas: the perceived level of 
difficulty experienced and the level of confidence regarding the ability to adhere to 
each recommendation.  The two subscales were measured on a 5-point scale and then 
combined to form a total self-efficacy score for each recommendation.  Please contact 
authors for a detailed explanation of this measure. 
Functional status was ascertained using two measures.  The New York Heart 
Association (NYHA) functional classification, assessed by the cardiologist, provided 
information regarding the degree of physical limitations according to four possible 
groups.  Class I patients’ lifestyle is not limited by CHF while Class IV patients are 
unable to perform any physical activity without experiencing discomfort. Left 
ventricular ejection fraction (LVEF) was obtained via an echocardiogram to assess the 
ability of the heart’s left ventricle to expel blood with each contraction (Bellg, 2004).   
Procedure 
Participants were interviewed according to a structured format. Five outpatients 
completed these over a week period.  The current LVEF and NYHA status was 
obtained from medical records by nursing staff. 
Statistical Analysis 
Patient characteristics and adherence behaviours were assessed via descriptive 
statistics. Gender and age differences were examined via independent sample t tests.  
A series of hierarchical regressions were performed to examine the relationship 
between independent variables and individual recommendations. The significance 
level was established at .05.  Raw data was examined and missing data appeared 
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random.  Fourteen cases with missing data (i.e., LVEF) were deleted, and 10 missing 
data cells substituted with the variable mean, leaving a total of 102 participants 
included within the analysis.   
Results 
Demographic and Clinical Characteristics 
 Demographical data and scores obtained on the psychometric measures were 
compared between the in-patient and outpatient groups via t test statistics.  No 
between group differences were found regarding educational attainment, employment 
status, gender or age.  More of the out-patient group were married compared with the 
in-patient group, t(87.87) =  2.42, p < .05.  No differences were found between the in-
patient group (M = 46.68, SD = 6.41) and outpatient groups (M = 46.29, SD = 4.83) 
regarding their level of trait anxiety as measured on the STAI.  Similarly, no 
differences were found between the in-patient group (M = 9.78, SD = 8.22) and 
outpatient groups (M = 9.23, SD = 5.85) regarding their level of depression as 
measured by the BDI.  The level of adherence on target behaviours was compared.  
Groups were found to differ significantly in only one adherence area, with the 
outpatient group adhering more frequently to the daily weighing recommendation 
than the in-patient group, t(78.18) =  -2.36, p < .05.  These two groups will be 
considered together in further analysis and the demographic characteristics of this 
combined sample are presented in Table 1. The participant group was relatively 
young (M = 63.57 years, SD = 14.23, Range = 26 to 98) and predominantly male 
(70.6%).  Participants experienced moderate functional (NYHA M = 2.63, SD = .68) 
and physiological impairment (LVEF M = 32.90%, SD = 14.21).  
Participant reported depression appeared minimal but variable (M = 9.61, SD = 
7.65).  Minimal depressive symptoms (BDI < 10) were reported by 66.7% of 
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participants, 21.6% reported mild depression (10 to16), 6.9% reported moderate levels 
(17 to 29), and 5.9% experienced severe depression (BDI > 29). Based upon the 
criteria of a score greater than 10 being indicative of depression (Beck & Steer, 1993), 
33.3% of participants reported depression.  The overall mean trait anxiety score for 
the patient population was 35.47 although variability was noted (SD = 10.35) with 
31.4% reporting significant anxiety (STAI–T > 40).  No gender differences were 
found, however, participants under 70 years of age reported higher levels of 
depression than older patients (t (90.1) = 1.90, p <.05). Participants under 70 years of 
age also experienced higher levels of anxiety (t (92.02) = 4.08, p < .05).  
Highest self-efficacy was reported regarding medications adherence (M = 9.81, 
SD = 1.10), followed by smoking (M = 9.37, SD = 1.83), daily weighing (M = 8.88, 
SD = 2.19) and alcohol adherence (M = 8.68, SD = 2.23).  Lower self-efficacy was 
reported regarding sodium restrictions (M = 8.03, SD = 2.24) and exercise protocols 
(M = 7.00, SD = 2.65).   
Adherence Behaviour 
Self-reported adherence was comparatively high regarding medication (91.2%) 
and smoking restrictions (87.3%).  Fluid adherence was reported by 47.9% of 
participants with 32.4% stating that fluid restriction was not at all or only somewhat 
important. Despite 79.4% of CHF patients reporting that daily weighing was 
important, only 34.3% performed this behaviour each day. One third of patients 
completely avoided alcohol despite 86.3% understanding the importance. Only 9.8% 
of participants adhered to daily sodium restrictions, despite 90.2% reporting such 
restrictions were important.  No participants reported 100% adherence to exercise 
protocols with 10.8% of individuals exercising on five or more days per week. While 
95.1% of patients stated that exercise was important, 47.1% reported a moderate 
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degree of difficultly following recommendations with 44.1% attributing non-
adherence to physical symptoms. Individuals over the age of 69 years (M = 6.67, SD 
= 2.37) reported significantly higher levels of exercise adherence, t (100) = 2.20, p < 
.05, than younger patients (M = 5.52, SD = 2.66). 
Reliability of the Study Specific Questionnaire 
The three common behaviours measured by the validated SCHFI and study 
specific questionnaire were compared using the Pearson correlation coefficient.  The 
relationship between scale scores was high regarding weighing behaviour (r = .71, p < 
.05), and moderate regarding sodium restrictions (r = .52, p < .05), and exercise 
adherence (r = .40, p < .05). This study specific questionnaire appeared to have 
reasonable concurrent validity.  
Correlation and Regression Statistics 
Hierarchial regression was used to examine the relationship between 
psychological factors (depression, anxiety and self-efficacy) and seven Australian 
Heart Foundation lifestyle recommendations.  Gender, age and functional status 
(NYHA and LVEF) were included as biological covariates within the first model in 
each regression.   Correlation coefficients and hierarchial regression summaries 
appear in Tables 2 and 3.   
Daily weighing regression models.  The covariates significantly explained 14% 
(Adjusted R² = .11) of the weighing variability, F (4, 97) = 3.96, p < .05.  LVEF was 
the only significant predictor, t = -3.24, p < .05.  Model 2 accounted for 27.6% of 
weighing variability, Adjusted R² = .22 (F (7, 94) = 5.12, p < .05). The three 
psychological variables accounted for 13.6% of variability in weighing behaviour, a 
significant proportion, after controlling for the effects of covariates, F Change (3, 94) 
= 5.87, p < .05.  As in model 1, diminished cardiac performance remained a 
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significant predictor of behaviour within the full model.  Consistent with the 
hypothesis, self-efficacy was a strong predictor (t = 4.13, p < .05), uniquely 
explaining 13.1% of variability (sr = .36). However, depression and anxiety failed to 
predict weighing behaviour.  
Sodium restriction regression models. The covariates failed to account for salt 
restriction variability (F (4, 97) = .48, p > .05). The linear combination of variables in 
model 2 accounted for 21.1% (Adjusted R²  = .15) of salt intake variability, F (7, 94) 
= 3.60, p < .05, representing a significant increase after accounting for covariate 
effects, F Change (3, 94) = 7.63, p < .01. Contrary to the hypothesis, depression (t = -
.19, p > .05) and anxiety (t = -.93, p > .05) failed to predict  behavioural variability. 
As hypothesised, self-efficacy regarding salt restrictions predicted adherence 
behaviour, uniquely accounting for 15.5% of variability, t = 4.31, p < .05, sr = .394.  
Fluid intake restriction regression models.   Neither the combination of 
covariates, F (4, 97) = 1.30, n.s., nor the linear combination of the entire group of 
variables, F (7, 94) = 1.72, n.s., predicted variation regarding fluid restriction.  
However, self-efficacy (t = 2.53, p < .05) uniquely accounted for 6.1% (sr =  .25) of 
the variation in fluid adherence.  Contrary to the hypothesis, depression and anxiety 
failed to predict fluid adherence.  
Administration of medication regression models. Model 1 failed to predict 
medication variability, F (4, 97) = .26, n.s.  Model 2 also failed to account for the self-
medication variability (F (7, 94) = .40, p > .05). No significant predictors for 
medication behaviour were demonstrated.  
Regular exercise regression model. The covariates failed to account for exercise 
variability, F (4, 97) = 2.30, p > .05.  However, participant’s age uniquely accounted 
for 5.9% of exercise variability, t = 2.51, p < .05.  Model 2 accounted for 21.8% 
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(Adjusted R² = 15.9%) of the variability in exercise adherence, F (7, 94) = 3.74, p < 
.05.  After controlling for covariate effects, psychological variables explained an 
additional 13.1% variability in exercise adherence, F Change (3, 94) = 5.26, p < .05. 
Participants functional status appeared to be a significant predictor, t = -1.99, p = .05, 
however, β scores suggests that this finding may reflect the correlation between age 
and NYHA.  As hypothesised, self-efficacy regarding exercise adherence significantly 
predicted reported behaviour, accounting for 11.8% of variability (t = -3.76, p < .05).  
Depression and anxiety failed to predict exercise adherence.  
Smoking restriction regression model. The covariates were unable to 
significantly explain smoking variability, F (4, 97) = 1.58, p > .05. Model 2 
significantly accounted for 22% (Adjusted R²  = 16.2%) of variability, F (7,94) = 
3.78, p < .05.  The inclusion of psychological variables increased prediction by 
15.9%, F Change (3, 94) = 6.37, p < .05. As hypothesised self-efficacy predicted 
smoking behaviour, explaining 14.2% of the variability in self-reported smoking 
restrictions, t = 4.14, p < .05. Anxiety accounted for 3.3% of variability (t = -2.01, p < 
.05) suggesting minimal practical predictive power while depression failed to predict 
smoking adherence.    
Alcohol restriction regression model.  The covariates failed to explain alcohol 
variability, F (4,97) = 1.18, p > .05.  Model 2 accounted for 36.1% (Adjusted R² = 
.314) of variability in alcohol consumption, F (7,94) = 7.60, p < .05. After controlling 
for covariate effects, the inclusion of psychological variables increased prediction by 
31.5%, F Change (3, 94) = 15.45, p < .05.  As hypothesised, anxiety predicted alcohol 
consumption (t = 2.24, p < .05) but only uniquely accounted for 3.4% (sr = .18) of 
variability while self-efficacy uniquely explained 24.3% of alcohol variability (t = 
5.98, p < .001, sr = .49).   Depression failed to predict alcohol adherence.  
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Discussion 
Consistent with previous research, adherence regarding self-medication was 
high compared with the other lifestyle recommendations. It appears easier for patients 
to self-medicate than modify lifestyle behaviours. Sodium restrictions and regular 
exercise were the areas most vulnerable to non-adherence with almost half of the 
participants attributing exercise non-adherence to comorbid medical conditions.  
However, the fact that older participants demonstrated higher levels of exercise 
adherence is difficult to interpret, as this was the only area where age differences were 
detected and these older patients were more likely to have severe cardiac 
incompetence.  Evangelista et al. (2003) also found older patients more compliant 
with exercise regimens.  The speculation that younger individuals may experience 
more difficulty secondary to employment and family commitments was not supported 
in this instance, as less than 5% of non-adhering patients attributed their difficulty to 
inconvenience or time constraints. With more than half of CHF patients reporting 
non-adherence to fluid restrictions it was interesting to note that patient fluid intake 
knowledge appeared relatively poor.  During interview, many patients stated that they 
drank the required six to eight glasses per day, thus appearing to confuse CHF 
recommendations with a commonly reported general health recommendation.   
The levels of adherence reported by participants suggest that nurses should 
consider all individuals (particularly younger patients regarding exercise) at risk of 
non-adherence and highlight fluid recommendations within existing educational 
programs. However, the finding that patients’ knowledge did not necessarily ensure 
strong adherence suggests that reliance upon self-maintenance education alone, may 
not be sufficient to promote and sustain optimal levels of adherence. 
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Consistent with previous research, one third of participants reported depressive 
symptomatology which exceeds the estimated 20% demonstrated by chronically ill 
patients (Faris et al., 2002), however, only 6% reported severe depression.  
Interestingly, almost one third of participants reported significant anxiety 
symptomatology.  Anxiety was found to be highly comorbid with depression and 
younger patients (< 70) appear at greater risk of experiencing both disorders. The 
younger patient may experience more fundamental disruptions to vocational, social 
and general quality of life commonly associated with an early lifespan phase and 
greater apprehension about their future.   
Depressed individuals did not appear to be at greater risk of non-adherence. 
Individuals reporting higher levels of anxiety were shown to be slightly more prone to 
non-adherence regarding alcohol and smoking restrictions. As proposed by Bellg 
(2004) and evidenced by the small negative relationship demonstrated between 
anxiety and the majority of recommended behaviours, a degree of anxiety may 
actually be beneficial to the promotion of adherence. Despite the failure to 
demonstrate a relationship between anxiety and depression and adherence, the high 
prevalence of both disorders within this cohort suggests that psychological assessment 
and care, would be an advantageous inclusion within routine nursing care.  
Behaviour specific self-efficacy was found to be a moderate to strong predictor 
of adherence to all behaviours except fluid and medication adherence. It may 
therefore be hypothesised that interventions aimed at improving behaviour specific 
self-efficacy may improve adherence and health status. This remains an area to be 
evaluated. The Australian National Heart Foundation (ANHF) and Medical Research 
Council Bellg (2004) argued that health professionals are unable to predict adherence 
above the level of chance.  Consequently, assessing individual’s level of self-efficacy 
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towards specific recommendations (easily accomplished via questions concerning 
perceived difficulty and confidence) may provide a more accurate indication of actual 
adherence behaviour.  
Limitations 
Reliance upon self-report regarding psychological morbidity and adherence 
behaviour  and the measurement of self-maintenance behaviours by an unvalidated 
study specific questionnaire, suggests that findings should be considered with caution.  
Reliance upon the BDI, which includes a number of symptoms (eg., sexual 
incompetence and fatigue) common to both CHF and depression, and failure to assess 
the client’s use of psychotropic agents or interventions, may have contributed to 
inaccuracies regarding depression measurement. 
Conclusion 
Patient adherence to prescribed lifestyle changes and medical regimens 
continue to pose a major challenge for health professionals. Expanding knowledge 
regarding the role and interplay of psychological predictors underlying adherence 
behaviour may help to more clearly discriminate between CHF patients who are at 
risk of rapid disease progression.   This study provides substantial information 
regarding patterns of adherence behaviour and evidence of prevalent psychological 
distress.  Despite depression and anxiety failing to significantly explain adherence 
behaviour, findings have implications for nursing staff regarding psychological 
screening and the implementation of interventions aimed at promoting self-efficacy.  
Deleted: be prognostic indicators 
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Table 1 
 
Demographic and Clinical Characteristics of Participants                      
_______________________________________________ 
 
Variable                                     Number             Percentage 
_______________________________________________ 
 
Gender 
          
           Male                                      72                       70.6         
          
           Female                                  30                        29.4  
 
Age 
                     
            Up to 65                               54                        52.9 
 
            Over 65                                48                        47.1 
 
Marital Status 
 
           Single                                    13                        12.7   
 
           Married/Defacto                   68                        66.7 
 
           Divorced                                 8                          7.8 
 
           Widow/Widower                  13                        12.7 
 
Education 
 
           Primary/Secondary               84                        82.4 
 
           Tafe/Apprenticeship              8                           7.8 
 
           University                             10                          9.8 
 
Employment Status 
 
           Employed                             18                         17.6 
 
           Unemployed                           4                           3.9 
 
           Retired/Pension                    80                         78.4 
 
NYHA Classification 
 
         Class I                                       6                          5.9 
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         Class II                                    28                        27.4 
 
         Class  III                                  58                        56.9 
 
         Class IV                                   10                          9.8 
 
Left Ventricular Ejection Fraction  
          
         Up to 45                                   85                        83.3      
 
         Over 45%                                17                        16.7 
_______________________________________________ 
 
Note.  n = 102  
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Table 2 
 
Bivariate Correlations between Study Variables  
 
Common to each Hierarchial Regression 
__________________________________________________ 
                            Age       Gender     LVEF     NYHF     BDI  
 
Age                    
 
Gender                .04 
 
LVEF                  .26**           .25** 
 
NYHF                 .52***         .09          -.07 
 
BDI                   -.20*          .12          -.17*               .05 
 
STAI                 -.36***       .18*         -.23*         -.11        .67*** 
__________________________________________________ 
 
*p < .05.  **p < .01.  ***p < .001 
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Table 3 
 
Summary of Hierachial Regression Results for Each Target Behaviour 
____________________________________________________________________________________________________________________
                                  Weighing           Sodium            Fluid           Medication       Exercise         Smoking        Alcohol  
 
                                   SE        β        SE         β        SE         β         SE         β       SE         β        SE        β        SE        β     
                                 ________________________________________________________________________________
 
Model      Variable 
 
1               Age           .02       -.05     .03      -.06      .02      -.06       .00       .01      .02       .31*       .01    -.25*          .02      .00 
 
                 Gender      .48      -.07      .79       .03      .54       .11       .11      -.10       .57       .18      .21     .11        .42      .18 
 
                 NYHA       .38       .00      .63       .11      .42      -.03       .08       .01      .45      -.15      .17     .18       .33       .10 
 
                 LVEF        .02      -.34**     .03       .11      .02        .17       .00     -.01      .02      -.07      .01     .03       .01      -.01 
 
2               Age           .02      -.07      .03      -.07      .02      -.06       .00     -.04       .02       .20      .01    -.29*        .01       .07 
 
                 Gender      .46      -.08      .76      -.01     .54        .13       .11     -.07       .58       .06      .20     .16       .36       .06 
 
                 NYHA      .36       .01       .58       .11     .42       -.03       .09      .01       .43      -.23*       .16     .18       .28       .03 
 
                 LVEF       .02      -.27**       .03       .11     .02        .16       .00     -.03       .02      -.06      .01   -.01        .01      .06 
 
                 BDI          .04       .04        .06     -.02     .04        .01       .01     -.03        .04       .00      .02    .21       .02      -.10 
 
                 STAI-T    .03       .07        .05     -.12      .03      -.02       .01     -.12        .03       .02      .01    .26*         .02       .27* 
 
                 Self-          
 
                 Efficacy   .12      .38***        .15      .42***   .12       .25*       .05        .03        .10     -.41***  .04    .39***     .07      .51***
_________________________________________________________________________________________________________________________________________________
 
Note.  *p < .05. ** p < .01. *** p < .001. 
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